A CASE OF KRAS-MUTATED JMML WITH HIGH METHYLATION PROFILE AND PERPLEXED CLINICAL COURSE.

• Vasiliki Tzotzola,
• Kondylia Antoniadi,
• Charikleia Kelaidi,
• Loizos Petrikkos,
• Elda Ioannidou,
• Evgenios Goussetis,
• Aikaterini Bountali,
• Kalliopi Manola,
• Elpidoforos Mantadakis,
• Kalliopi Stefanaki,
• Ioulia Peristeri,
• Charlotte Niemeyer,
• Sophia Polychronopoulou

Affiliations

Vasiliki Tzotzola

Department of Pediatric Hematology-Oncology (TAO), “Aghia Sophia” Children’s Hospital, Athens, Greece

Kondylia Antoniadi

Department of Pediatric Hematology-Oncology (TAO), “Aghia Sophia” Children’s Hospital, Athens, Greece

Charikleia Kelaidi

Department of Pediatric Hematology-Oncology (TAO), “Aghia Sophia” Children’s Hospital, Athens, Greece

Loizos Petrikkos

Department of Pediatric Hematology-Oncology (TAO), “Aghia Sophia” Children’s Hospital, Athens, Greece

Elda Ioannidou

Bone Marrow Transplantation Unit, “Aghia Sophia” Children’s Hospital, Athens, Greece

Evgenios Goussetis

Bone Marrow Transplantation Unit, “Aghia Sophia” Children’s Hospital, Athens, Greece

Aikaterini Bountali

Department of Pediatric Hematology-Oncology (TAO), “Aghia Sophia” Children’s Hospital, Athens, Greece

Kalliopi Manola

Cytogenetics, National Centre for Research “Demokritos”, Athens, Greece

Elpidoforos Mantadakis

Pediatric Clinic, University General Hospital of Alexandroupolis, Greece

Kalliopi Stefanaki

Department of Pathology, “Aghia Sophia” Children’s Hospital, Athens, Greece

Ioulia Peristeri

Bone Marrow Transplantation Unit, “Aghia Sophia” Children’s Hospital, Athens, Greece

Charlotte Niemeyer

Department of Pediatric Hematology and Oncology, Medical Center Freiburg-University of Freiburg, Germany

Sophia Polychronopoulou

Department of Pediatric Hematology-Oncology (TAO), “Aghia Sophia” Children’s Hospital, Athens, Greece